Getein Biotech, Inc (SHA:603387)
China · Delayed Price · Currency is CNY 9.60
+0.45 (4.92%)
Apr 30, 2026, 1:25 PM CST
Getein Biotech Market Cap
Getein Biotech has a market cap or net worth of 4.64 billion as of April 29, 2026. Its market cap has increased by 5.54% in one year.
Market Cap
4.64B
Enterprise Value
4.24B
Revenue
1.04B
Ranking
n/a
PE Ratio
22.29
Stock Price
9.60
Market Cap Chart
Since July 17, 2017, Getein Biotech's market cap has increased from 4.23B to 4.64B, an increase of 9.72%. That is a compound annual growth rate of 1.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 4.64B | 9.32% |
| Dec 31, 2025 | 4.24B | 1.45% |
| Dec 31, 2024 | 4.18B | -25.00% |
| Dec 29, 2023 | 5.58B | -12.00% |
| Dec 30, 2022 | 6.34B | -12.61% |
| Dec 31, 2021 | 7.25B | -18.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition